182 related articles for article (PubMed ID: 9363385)
1. Hepatic uptake of Tc-99m MDP on bone scintigraphy from intravenous iron therapy (Blutal).
Park CH; Kim HS; Shin HY; Kim HC
Clin Nucl Med; 1997 Nov; 22(11):762-4. PubMed ID: 9363385
[TBL] [Abstract][Full Text] [Related]
2. [Cause for visualization of the liver in bone scintigraphy--the effect of the combined use of iron chondroitin sulfate (Blutal)].
Tanaka S; Sawa H; Fukuda T; Tanaka M; Tsujita Y; Yahata S; Nakajima H; Taniguchi S; Inoue Y; Omura M
Kaku Igaku; 1983 Sep; 20(8):1175-81. PubMed ID: 6231399
[No Abstract] [Full Text] [Related]
3. Idiopathic hepatic uptake of (99m)Tc methylene diphosphonate: a case report.
MacDonald J
J Nucl Med Technol; 2001 Mar; 29(1):32-6. PubMed ID: 11283215
[TBL] [Abstract][Full Text] [Related]
4. Diffuse liver uptake of Tc-99m phosphate compound associated with intravenous injection of iron colloid solution.
Eshima M; Shiozaki H; Ishino Y; Nakata H
Clin Nucl Med; 1993 Apr; 18(4):348-9. PubMed ID: 8482036
[No Abstract] [Full Text] [Related]
5. Pathologic hepatic Tc-99m-MDP uptake in polyostotic fibrous dysplasia.
Kekilli E; Yagmur C; Kuzucu A; Soysal O; Cikim AS; Ertem K
Ann Nucl Med; 2004 Oct; 18(7):627-30. PubMed ID: 15586638
[TBL] [Abstract][Full Text] [Related]
6. The effect of MRI contrast agents on hepatic and splenic uptake in the rabbit during (99m) Tc-MDP bone scintigraphy.
Qiu L; Tang Y; Chen Y; Huang Z; Zhu Y; Zhang L; Cai L; Wan Q; Feng Y
Contrast Media Mol Imaging; 2015; 10(6):438-45. PubMed ID: 26036779
[TBL] [Abstract][Full Text] [Related]
7. Hepatic amyloidosis in an i.v. drug abuser detected by bone scintigraphy.
Ferraro EM; Alfelor FR; Lee M; Poon TT
Clin Nucl Med; 1987 Apr; 12(4):274-6. PubMed ID: 3581606
[TBL] [Abstract][Full Text] [Related]
8. Diffuse liver uptake on (99m)Tc-MDP bone scan secondary to severe hepatic failure.
Chen P; Marentis T; Brown RK
Clin Nucl Med; 2014 Jul; 39(7):658-9. PubMed ID: 24873795
[TBL] [Abstract][Full Text] [Related]
9. Diffuse hepatic and splenic uptake of Tc-99m methylene diphosphonate on bone scintigraphy after intravenous administration of gadolinium-containing MRI contrast.
Shi X; Jing H; Zhuang H; Zhang Y; Jin X; Li F
Clin Nucl Med; 2011 Mar; 36(3):178-82. PubMed ID: 21285673
[TBL] [Abstract][Full Text] [Related]
10. Different findings in Tc-99m MDP bone scintigraphy of patients with sickle cell disease: report of three cases.
Cerci SS; Suslu H; Cerci C; Yildiz M; Ozbek FM; Balci TA; Yesildag A; Canatan D
Ann Nucl Med; 2007 Jul; 21(5):311-4. PubMed ID: 17634851
[TBL] [Abstract][Full Text] [Related]
11. Hepatic and splenic uptake of Tc-99m HDP in multiple myeloma: additional findings on Tc-99m MIBI and Tc-99m sulfur colloid images.
Berk F; Demir H; Hacihanefioglu A; Arslan A; Erdincler O; Isgoren S; Aktolun C
Ann Nucl Med; 2002 Apr; 16(2):137-41. PubMed ID: 12043908
[TBL] [Abstract][Full Text] [Related]
12. Abnormal uptake of Technetium-99 m hydroxymethylene diphosphonate in the liver.
Roman MR; Larcos G; Angelides S; Devadas M
Australas Radiol; 2003 Mar; 47(1):73-4. PubMed ID: 12581061
[TBL] [Abstract][Full Text] [Related]
13. Visualization of metastatic liver disease on technetium-99m bone scintigraphy.
Romyn AM; Bushnell DL; Freeman ML; Kaplan E
Clin Nucl Med; 1987 Apr; 12(4):264-7. PubMed ID: 3581604
[TBL] [Abstract][Full Text] [Related]
14. Liver uptake and increased renal uptake of Tc-99m HMDP in a patient with iron overload.
Ohta H
Clin Nucl Med; 2001 Feb; 26(2):164-5. PubMed ID: 11201486
[No Abstract] [Full Text] [Related]
15. Diffuse liver and splenic activity with Tc-99m MDP associated with iohexol injection. A case report.
Poulton TB; Rauchenstein JN; Murphy WD
Clin Nucl Med; 1992 Nov; 17(11):864-5. PubMed ID: 1424374
[No Abstract] [Full Text] [Related]
16. Bone agent localization in hepatic metastases.
Shih WJ; Han JK; Magoun S; Wierzbinski B
J Nucl Med Technol; 1999 Mar; 27(1):38-40. PubMed ID: 10322573
[TBL] [Abstract][Full Text] [Related]
17. Bilateral symmetrical Ollier disease and Tc-99m MDP bone scintigraphy.
Kaya H; Komek H; Cerci SS; Tuzcu SA
Clin Nucl Med; 2004 Jul; 29(7):456. PubMed ID: 15192478
[No Abstract] [Full Text] [Related]
18. Hepatic uptake of a bone scan agent (99mTc-MDP) in a patient with amyloidosis associated with plasma cell dyscrasia.
Jones DN; Lew W; Wycherley AG
Australas Radiol; 1994 Feb; 38(1):61-3. PubMed ID: 8147806
[TBL] [Abstract][Full Text] [Related]
19. Is (99m)Tc-labelled pamidronate a better agent than (99m)Tc-medronate for bone imaging?
Kumar V; Kumar D; Howman-Giles RB; Little DG
Nucl Med Commun; 2007 Feb; 28(2):101-7. PubMed ID: 17198350
[TBL] [Abstract][Full Text] [Related]
20. Hepatic and splenic uptake on bone scintigraphy in patients with intravenous administration of 99mTc methylene diphosphonate prior to gadolinium-containing contrast.
Zhang W; Chen B; Deng H; Yang T; Ou X
Clin Nucl Med; 2013 Mar; 38(3):219-20. PubMed ID: 23412599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
